Publications by authors named "Sarah Schramke"

Article Synopsis
  • Large animal models like transgenic Huntington disease minipigs have been suggested to enhance the reliability of preclinical studies due to their genetic similarity and brain structure to humans.
  • The study aimed to determine if vocalization can be used to identify and differentiate transgenic Huntington disease minipigs from wildtype counterparts, focusing on behavioral assessments.
  • Results showed that vocalization can effectively indicate differences between tgHD and wt minipigs, providing a valuable non-invasive method to monitor disease progression and phenotypic changes over time.
View Article and Find Full Text PDF

Background: Huntington's disease (HD) is an autosomal-dominant, progressive neurodegenerative disorder with motor, cognitive, behavioral and metabolic symptoms. HD patients exhibit an altered response to stress which is reflected in changes of cortisol levels. Large animal models of HD such as the Libechov minipig are currently explored in preclinical studies to improve translational reliability and assessing behavior is of interest.

View Article and Find Full Text PDF

Background: Large animal models of Huntington's disease (HD) may increase the reliability of translating preclinical findings to humans. Long live expectancy offers opportunities particularly for disease modifying approaches, but also challenges. The transgenic (tg) HD minipig model assessed in this study exhibits a high genetic homology with humans, similar body weight, and comparable brain structures.

View Article and Find Full Text PDF

Background: While several novel therapeutic approaches for HD are in development, resources to conduct clinical trials are limited. Large animal models have been proposed to improve assessment of safety, tolerability and especially to increase translational reliability of efficacy signals obtained in preclinical studies. They may thus help to select candidates for translation to human studies.

View Article and Find Full Text PDF

Background: As novel treatment approaches for Huntington's disease (HD) evolve, the use of transgenic (tg) large animal models has been considered for preclinical safety and efficacy assessments. It is hoped that large animal models may provide higher reliability in translating preclinical findings to humans, e.g.

View Article and Find Full Text PDF